Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 7, 2001

View Archived Issues

Dose-response study completed for Corvas's thrombosis prophylactic rNAPc2

PhotoCure applies for approval of photodynamic skin cancer therapy throughout Europe

NCI awards Phase I SBIR grant to Kosan Biosciences for anticancer compound

FDA places TP-10 pediatric trials on hold

Novel benzothiophene HSV-1 inhibitor identified by Pfizer

YM-471 shows potent affinity and selectivity for human vasopressin V1A and V2 receptors

Chronic dronedarone differs strongly from chronic amiodarone in the canine heart

Shire's once-daily treatment for ADHD receives FDA approvable letter

Cell Pathways begins phase II trials of CP-461 in several types of cancer

Vion initiates phase II clinical trials of Triapine for metastatic breast cancer

FDA approves new seven-day treatment for community-acquired pneumonia

Novel caspase inhibitors patented by Vertex

Lilly identifies compounds useful for potentiating glutamate receptor function

Benzyl tetralins reported to have potential in treating androgen- or estrogen-mediated diseases

Oxadiazolin-2-ones with elastase inhibitory activity reported by Ono Pharmaceuticals

Merck & Co. presents new cytokine inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...